Legend Biotech (LEGN) revenue breakdown
By region, United States of America is the largest at 100% of fiscal 2024 revenue, growing 25% a year over 5 years.
Revenue by region
Fiscal years, as Legend Biotech reports them in its 10-K filings; fiscal 2024 total $145M.
| Regions | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | Share |
|---|---|---|---|---|---|---|---|
| United States of America | $48M | $57M | $65M | $50M | $35M | $144M | 100% |
| China | $1M | $3,000 | $3M | $328,000 | $179,000 | $320,000 | 0% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for LEGN.
Open LEGN in InvestinglyQuestions
Where does Legend Biotech make its money?
In fiscal 2024, by region: United States of America $144M, China $320,000.
From Legend Biotech's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.